Picture of Cell Source logo

CLCS Cell Source Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Annual cashflow statement for Cell Source, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-4.56-5.47-5.17-5.32-4.51
Non-Cash Items1.361.390.4660.7550.048
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.4230.7011.562.221.78
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Cash from Operating Activities-2.77-3.38-3.14-2.35-2.68
Financing Cash Flow Items-0.04-0.353-0.028-0.2790.111
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities2.993.233.272.152.74
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.217-0.1520.13-0.20.052